Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kaye

Showing results (691-700 of 740) with videos related to

Pageof 74
Sort By:
Antimicrobial Agents and Chemotherapy|May 7, 2014
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional networkDavid van Duin, Federico Perez, Susan D Rudin, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
Infection Control and Hospital Epidemiology|August 7, 2013
Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in Southeastern MichiganPritish K Tosh, Simon Agolory, Bethany L Strong, et al.
Open Forum Infectious Diseases|February 12, 2021
Validation of N95 Filtering Facepiece Respirator Decontamination Methods Available at a Large University HospitalKrista R Wigginton, Peter J Arts, Herek L Clack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancerS K Sandhu, A Omlin, L Hylands, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2022
Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US HospitalsCourtney L Luterbach, Liang Chen, Lauren Komarow, et al.
Journal of Clinical Microbiology|March 7, 2014
Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing methodDror Marchaim, Jason M Pogue, Oran Tzuman, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 29, 2013
Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolationK Hayakawa, D Marchaim, P Bathina, et al.
Infection Control and Hospital Epidemiology|March 19, 2021
A "resistance calculator": Simple stewardship intervention for refining empiric practices of antimicrobials in acute-care hospitalsShani Zilberman-Itskovich, Nathan Strul, Khalil Chedid, et al.
Pageof 74

Showing results (691-700 of 740) with videos related to

Sort By:
Pageof 74
Antimicrobial Agents and Chemotherapy|May 7, 2014
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional networkDavid van Duin, Federico Perez, Susan D Rudin, et al.
The New England Journal of Medicine|March 7, 2014
Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIVPablo Tebas, David Stein, Winson W Tang, et al.
Infection Control and Hospital Epidemiology|August 7, 2013
Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in Southeastern MichiganPritish K Tosh, Simon Agolory, Bethany L Strong, et al.
Open Forum Infectious Diseases|February 12, 2021
Validation of N95 Filtering Facepiece Respirator Decontamination Methods Available at a Large University HospitalKrista R Wigginton, Peter J Arts, Herek L Clack, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Poly (ADP-ribose) polymerase (PARP) inhibitors for the treatment of advanced germline BRCA2 mutant prostate cancerS K Sandhu, A Omlin, L Hylands, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2022
Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US HospitalsCourtney L Luterbach, Liang Chen, Lauren Komarow, et al.
Journal of Clinical Microbiology|March 7, 2014
Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing methodDror Marchaim, Jason M Pogue, Oran Tzuman, et al.
Clinical Pharmacology and Therapeutics|June 17, 2025
Population Pharmacokinetic/Toxicodynamic Model for Polymyxin B in Critically Ill Patients to Identify the Risk of NephrotoxicityPatrick O Hanafin, Ramya Mahadevan, Gauri G Rao, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 29, 2013
Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolationK Hayakawa, D Marchaim, P Bathina, et al.
Infection Control and Hospital Epidemiology|March 19, 2021
A "resistance calculator": Simple stewardship intervention for refining empiric practices of antimicrobials in acute-care hospitalsShani Zilberman-Itskovich, Nathan Strul, Khalil Chedid, et al.
Pageof 74